Earnings Feed
Start Free
MERRIMACK PHARMACEUTICALS INC·4

Dec 17, 5:10 PM ET

Khan Fazal R. 4

4 · MERRIMACK PHARMACEUTICALS INC · Filed Dec 17, 2012

Insider Transaction Report

Form 4
Period: 2012-12-13
MERRIMACK PHARMACEUTICALS INCMACK
Khan Fazal R.
SVP of Manufacturing
Transactions
  • Exercise/Conversion

    Common Stock

    2012-12-13$1.71/sh+25,000$42,750→ 25,000 total
  • Sale

    Common Stock

    2012-12-13$6.73/sh−25,000$168,320→ 0 total
  • Exercise/Conversion

    Common Stock

    2012-12-17$1.71/sh+25,000$42,750→ 25,000 total
  • Sale

    Common Stock

    2012-12-17$6.41/sh−25,000$160,343→ 0 total
  • Exercise/Conversion

    Stock Option (right to buy)

    [F1]
    2012-12-13−25,000→ 125,000 total
    Exercise: $1.71Exp: 2016-02-24→ Common Stock (25,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    [F1]
    2012-12-17−25,000→ 100,000 total
    Exercise: $1.71Exp: 2016-02-24→ Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]This option is fully vested.
Signature
/s/ Jeffrey A. Munsie, attorney-in-fact|2012-12-17

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -